The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Preoperative radiation therapy with concurrent capecitabine, bevacizumab, and erlotinib for rectal adenocarcinoma: A phase I trial.
Prajnan Das
Research Funding - Genentech
Cathy Eng
No relevant relationships to disclose
Miguel A. Rodriguez-Bigas
Honoraria - Genomic Health
George J. Chang
Research Funding - ASCO Foundation Career Development Award
John Michael Skibber
No relevant relationships to disclose
Dipen Maru
No relevant relationships to disclose
Mark F. Munsell
No relevant relationships to disclose
Marilyn V. Clemons
No relevant relationships to disclose
Scott Kopetz
Consultant or Advisory Role - Roche
Research Funding - Roche
Chris R. Garrett
Consultant or Advisory Role - Genentech
Research Funding - Genentech
Imad Shureiqi
No relevant relationships to disclose
Sunil Krishnan
Research Funding - Genentech
Marc E. Delclos
No relevant relationships to disclose
Christopher H. Crane
Research Funding - Genentech